We use cookies to help us improve your browsing experience and understand how people use our website. Our privacy statement explains how we use cookies, and how to change your cookie settings.
OK
Novel targets

Full year 2019 results

Press release
Thursday 20 Feb 22.01 CET

Conference call
Friday 21 Feb 14:00 CET
Register for the webcast
Dial-in details

We are Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives. 

Learn more about Galapagos

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Current Openings

Loading...

All Current Openings